Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA support for Lilly cancer drug comes down to unmet needs vs side effects
FDA support for Lilly cancer drug comes down to unmet needs vs side effects
FDA support for Lilly cancer drug comes down to unmet needs vs side effects
Submitted by
admin
on July 11, 2015 - 10:34am
Source:
BioPharma Dive
News Tags:
FDA
Eli Lilly
necitumumab
non-small cell lung cancer
Headline:
FDA support for Lilly cancer drug comes down to unmet needs vs side effects
Do Not Allow Advertisers to Use My Personal information
